Exploring the measurement properties of the Montreal Cognitive Assessment in a population of people with cancer

Arcuri, Giovanni G.; Palladini, Lisa; Dumas, Gabrielle; Lemoignan, Josée; Gagnon, Bruno

doi:10.1007/s00520-015-2643-7

Cited by 19 publications

(12 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, the participants will be asked to connect numbers and letters in a defined sequence, count backwards from 100 by increments of 7, draw different figures and perform word associations. The MoCA total score (/30) is obtained by summing the scores from each item; a cut-off score below 26 is an indicator of mild cognitive impairment [ 41 ]. The TMT, evaluating processing speed and cognitive flexibility, consists of connecting numbers in ascending order (Part 1) and then in connecting numbers and letters in both ascending and alphabetical order (Part 2), as fast as possible [ 42 ].…”

Section: Methodsmentioning

confidence: 99%

Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol

et al. 2021

View full text Add to dashboard Cite

Background Cancer-related fatigue (CRF) is the most common side effect of cancer and cancer treatment. CRF prevalence is up to 50% in breast cancer patients and can continue several years after cancer remission. This persistent subjective sense of exhaustion is multifactorial. Numerous parameters have been evidenced to be related to CRF across biological, physical, psychological, social and/or behavioral dimensions. Although CRF has been studied for many years, the majority of previous studies focused on only one dimension, i.e., physical function. Moreover, few studies investigated CRF longitudinally with repeated measures. These are the two main obstacles that limit the understanding of CRF mechanisms. The purpose of this study is to create a biopsychosocial model of CRF with simultaneous and longitudinal anthropometric, clinical, biological, physical, psychological and sociological parameters. Methods BIOCARE FActory is a multicentric prospective study that will consist of an 18-month follow-up of 200 women diagnosed with breast cancer. Four visits will be scheduled at diagnosis, after treatments, and 12 and 18 months after diagnosis. The same procedure will be followed for each visit. Each session will be composed of anthropometric data collection, a semi-structured interview, cognitive tests, postural control tests, neuromuscular fatigability tests and a cardiorespiratory fitness test. Clinical and biological data will be collected during medical follow-ups. Participants will also complete questionnaires to assess psychological aspects and quality of life and wear an actigraphy device. Using a structural equation modeling analysis (SEM), collected data will build a biopsychosocial model of CRF, including the physiological, biological, psychological, behavioral and social dimensions of CRF. Discussion This study aims to highlight the dynamics of CRF and its correlates from diagnosis to post treatment. SEM analysis could examine some relations between potential mechanisms and CRF. Thus, the biopsychosocial model will contribute to a better understanding of CRF and its underlying mechanisms from diagnosis to the aftermaths of cancer and its treatments. Trial registration This study is registered at ClinicalTrials.gov (NCT04391543), May 2020.

show abstract

Section: Methodsmentioning

confidence: 99%

Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The MoCA is a one-page, 30-point test originally devised to screen for mild cognitive impairment in the geriatric population and can also be applied to evaluate the level of cognition of cancer survivors. 42 The validated Korean version of the MoCA will be used in this study. 43 The MoCA will be assessed at baseline and week 5 by the assessors who will be blinded to the group allocation.…”

Section: Methods and Analysismentioning

confidence: 99%

Electroacupuncture for treating insomnia in patients with cancer: a study protocol for a randomised pilot clinical trial

Kim

Lee

et al. 2017

BMJ Open

View full text Add to dashboard Cite

IntroductionAlthough insomnia is one of the most prevalent and disturbing symptoms among patients with cancer, it has not been properly managed. Electroacupuncture (EA) has received attention as a promising intervention for insomnia, and a few previous studies have reported that this intervention may be beneficial for treating insomnia in patients with cancer. The aim of this pilot study is to explore the feasibility and preliminary effectiveness of EA on the sleep disturbance of patients with cancer with insomnia using a subjective method, patient-reported questionnaires and an objective tool, actigraphy, to measure the quality of sleep.Methods and analysisThis is a study protocol for a randomised, three-arm, multicentre, pilot clinical trial. A total of 45 patients with cancer who have continuous insomnia related to cancer treatment or cancer itself will be randomly allocated to an EA group, sham EA group or usual care group in equal proportions. The EA group will receive 10 sessions of EA treatment over 4 weeks. The sham EA group will receive sham EA at non-acupoints using non-penetrating Streitberger acupuncture needles with mock EA. The usual care group will not receive EA treatment. All participants will be provided a brochure on the management of sleep disorders regardless of their group assignment. The primary outcome measure is the mean change in the insomnia severity index from the baseline to week 5. Information related to sleep quality will also be obtained through the Pittsburgh Sleep Quality Index, a sleep diary and actigraphy. Participants will complete the trial by visiting the research centre at week 9 for follow-up assessment.Ethics and disseminationThis study protocol was approved by the institutional review boards of each research centre. Written informed consent will be obtained from all participants. The result of this study will be published in peer-reviewed journals or presented at academic conferences.Trial registration numberKCT0002162; Pre-results.

show abstract

“…The latter is based on each subject’s performance: the more difficult the item that the subject performs correctly, the higher the ability score, and vice versa [ 16 – 19 ]. Although Rasch analysis has been widely applied to create improved instruments from well-validated questionnaires [ 20 – 26 ], and despite the increasing number of studies trying to develop a composite score (using both cognitive and functional measures) [ 27 – 30 ], no study, at least to our knowledge, has used the Rasch model to develop a comprehensive instrument derived from the combination of different items of different tests for measuring global functioning.…”

Section: Introductionmentioning

confidence: 99%

Measuring global functioning in older adults with cognitive impairments using the Rasch model

et al. 2020

View full text Add to dashboard Cite

Background Cognitive and functional measures are often measured and interpreted separately during the clinical evaluation of patients with cognitive impairment. This can sometimes lead to a challenging interpretation when measures do not show concordance, especially after a clinical intervention. In this study, the development and evaluation of a new approach, using the Rasch model, that combines cognitive and functional measures in one single and more powerful measure (compared to stand-alone tests) to assess global functioning in older adults with cognitive impairment (including dementia) was presented. Methods Clinical data from 265 older adults’ subjects diagnosed with mild cognitive impairment, or dementia, included: The Mini-mental state examination (MMSE), the Esame Neuropsicologico Breve (ENB) – a neuropsychological battery used in Italy–, the Activities of Daily Living (ADL), and the Instrumental Activities of Daily Living (IADL) questionnaires. Results Patients with severe cognitive impairment showed lower global functioning score compared to patients with moderate impairment. Receiver Operating Characteristic (ROC) curve analyses were performed to determine sensitivity and specificity of the global functioning score resulting from the combined measure. Results showed that the global functioning score discriminates better between patients with severe and moderate cognitive impairment compared to the ENB, ADL, and IADL when considered separately. Conclusions The Rasch model was able to combine cognitive and functional measures into a single score (global functioning score). All together, these results suggest that the diverse cognitive and functional measures can be considered part of one single dimension (global functioning) and that this dimension can be measured as a single construct and score. This study offers an alternative perspective for future development of instruments that would help clinicians in measuring global functioning in older adults’ patients at different stages of cognitive impairments and different baseline level of performance.

show abstract

Exploring the measurement properties of the Montreal Cognitive Assessment in a population of people with cancer

Cited by 19 publications

References 44 publications

Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol

Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol

Electroacupuncture for treating insomnia in patients with cancer: a study protocol for a randomised pilot clinical trial

Measuring global functioning in older adults with cognitive impairments using the Rasch model

Contact Info

Product

Resources

About